Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-20

Clinical Trial Update: Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis. [NA]

View source ↗

Summary

It reports a clinical trial evaluating the safety and effectiveness of sulfasalazine for liver fibrosis and cirrhosis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Cirrhosis, Liver, Fibrosis, Liver | NA | Status: RECRUITING